OTC · Financial Statements
Kane Biotech Inc. (KNBIF) Financial Statements
$0.02
OTC: KNBIF
Market Cap $4.13M
Overview Financials Dividend Kane Biotech Inc. most recently reported annual revenue of $0, net profit of $-3.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $2.0M $3.0M $0 $2.0M $0 Operating Profit $-5.0M $-3.0M $-3.0M $-4.0M $-3.0M Net Profit $-5.0M $-4.0M $-5.0M $6.0M $-3.0M EPS $-0.04 $-0.03 $-0.04 $-0.02 $-0.02 Op Margin -303.8% -129.6% -2253.6% -188.5% -727.4%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $6.0M $6.0M $6.0M $2.0M $3.0M Total Liabilities $8.0M $10.0M $14.0M $4.0M $3.0M Cash $1.0M $1.0M $1.0M $0 $1.0M Borrowings $5.0M $7.0M $9.0M $2.0M $2.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-2.0M $-3.0M $-3.0M $-4.0M $-3.0M Investing Cash Flow $-1.0M $0 $0 $10.0M $0 Financing Cash Flow $2.0M $0 $3.0M $-1.0M $0 Net Cash Flow $0 $0 $0 $-2.0M $1.0M Free Cash Flow $-3.0M $-3.0M $-3.0M $-4.0M $-3.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.02 EV / EBITDA -2.66 FCF Yield -50.92% Quick Ratio 0.27 Interest Coverage -10.86 Return 1Y -30.48% Return 3Y -69.75% Return 5Y —
Screens featuring this stock